Cytodyn Inc (CYDY)

[IsldrInTheMtns]

All the BLA submission concerns should be eased by this statement in the Quarterly Report. There are substantial options (financial) incentives that only get activated when the BLA is filed. It's a 10yr contract sure but further extended filing delays could kill the value of the "eventual" execution. Total 3.25M shares (~$10M at ~$3 SP) is a pretty strong incentive.

Hoping Leronlimab is everything it appears to be and Cytodyn gets the large scale traction that would warrant.

Disclosure: I'm a new investor. 12k at ~2.75. & 1k in each of my twins' custodial accts.


[i]"On December 19, 2019, the Company issued stock options covering 7,300,000 shares of its common stock to directors, executives, and a consultant, of which 7,100,000 were granted under the 2012 Plan and 200,000 were granted outside of the 2012 Plan. The stock option awards have a per share exercise price of $0.63. Stock options covering 6,050,000 shares vested immediately upon issuance and 1,250,000 shares will vest upon filing of the BLA associated with HIV-combination therapy. In addition, the president and chief executive officer received a warrant awarded outside of the 2012 Plan covering 2,000,000 shares with an exercise price of $0.63 per share, which vests upon the Company’s filing of the BLA. The grant date fair value related to these stock options was approximately $2.7 million and each has a ten-year contractual term."